RxDoctor Payments Data

Steven Potter, MD

Family Medicine · Rigby, IDNPI 1407922446

Payments from drug & device makers

$963in general payments, 2019–2025

Across 52 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$135
  • Axsome Therapeutics, Inc.$96
  • Otsuka America Pharmaceutical, Inc.$85
  • Boston Scientific$84
  • GSK$65
  • Antares Pharma, Inc.$63
  • plus $434 from 17 others

What the payments were for

  • Food & beverage$92997%
  • Education$343%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$963 in reported general payments places this provider in the 70th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$86,312
Medicare patients
194
Services billed
1,147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban74$65,552
OzempicSemaglutide59$56,471
MounjaroTirzepatide44$43,620
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$34,865
JardianceEmpagliflozin30$23,339
XareltoRivaroxaban31$19,989
Aripiprazole83$8,599
JanuviaSitagliptin Phosphate14$8,559
Celecoxib56$3,997
Ondansetron OdtOndansetron45$2,865
Levothyroxine Sodium263$2,842
Gabapentin125$2,525
Testosterone Cypionate45$2,497
Dexlansoprazole DrDexlansoprazole14$2,326
Cefdinir81$2,300

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$16$65,55274 claims
Novo NordiskOzempic$13$56,47159 claims
Lilly USA, LLCMounjaro$44$43,62044 claims
GSKTrelegy Ellipta$65$34,86547 claims
Johnson & JohnsonXarelto$16$19,98931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 803 family medicine providers in Idaho.

Other family medicine in Rigby

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →